TREA

98065183 - FERTIN

Follow

Information

  • Trademark
  • 98065183
  • Serial Number
    98065183
  • Filing Date
    June 29, 2023
    2 years ago
  • Transaction Date
    July 27, 2025
    2 months ago
  • Status Date
    July 25, 2025
    2 months ago
  • Published for Opposition Date
    December 10, 2024
    10 months ago
  • Location Date
    February 04, 2025
    8 months ago
  • Status Code
    730
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    SINGER, MELANIE
  • Attorney Docket Number
    FERT 2307676
    Attorney Name
    Tamar Niv Bessinger
    Law Office Assigned Location Code
    M30
  • Owners
Information
Mark Drawing Code
4
Mark Identification
FERTIN
Case File Statements
  • GS0401: Custom manufacture of pharmaceuticals and nutraceuticals; consultancy regarding the custom manufacture of pharmaceuticals and nutraceuticals; provision of advice, information and consultancy in relation to the aforesaid services
  • GS0051: Pharmaceutical preparations for smoking cessation; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of insomnia and sleep disorders, and to improve quality and quantity of sleep; pharmaceutical preparations to treat fever; pharmaceutical preparations to treat inflammation; Pharmaceutical preparations for the treatment of arthritis; psychotherapeutic pharmaceutical preparations; pharmaceutical preparations for treatment of cold; Pharmaceutical preparations for treatment of flu; Pharmaceutical preparations for treatment of cough; Pharmaceutical preparations for treatment of sinus; Pharmaceutical preparations for treatment of allergy; Pharmaceutical preparations for treatment of cardiovascular diseases; Pharmaceutical preparations for treatment of neurological disorders; Pharmaceutical preparations for treatment of chronic pain; Pharmaceutical preparations for treatment of gastro-intestinal disorders; vitamins; dietary supplements prepared from fruit extracts; dietary supplements prepared from vegetable extracts; dietary supplements prepared from herbal extracts; dietetic supplements prepared from herbal extracts; dietetic supplements prepared from fruit extracts; dietetic supplements prepared from vegetable extracts; nicotine chewing gum for use as aid to stop smoking; medicated chewing gum; dietetic substances adapted for medical use; herbal extracts for medical purposes; herbal teas for medicinal purposes
  • GS0421: Research and development of technology in the field of smoking cessation preparations; research and development of technology in the field of analgesics; research and development of technology in the field of sleep aid drugs; research and development of technology in the field of anti-pyretic drugs; research and development of technology in the field of anti-inflammatory preparations; research and development of technology in the field of pharmaceutical preparations for the treatment of arthritis; research and development of technology in the field of psychotherapeutic preparations; research and development of technology in the field of pharmaceutical preparations for treatment of cold; research and development of technology in the field of pharmaceutical preparations for treatment of flu; research and development of technology in the field of pharmaceutical preparations for treatment of cough; research and development of technology in the field of pharmaceutical preparations for treatment of sinus; research and development of technology in the field of pharmaceutical preparations for treatment of allergy; research and development of technology in the field of pharmaceutical preparations for treatment of cardiovascular diseases; research and development of technology in the field of pharmaceutical preparations for treatment of neurological disorders; research and development of technology in the field of pharmaceutical preparations for treatment of chronic pain; research and development of technology in the field of pharmaceutical preparations for treatment of gastro-intestinal disorders; design of new products for others; scientific and technological services in the nature of testing of new products for others; medical research services; scientific research services; pharmaceutical products development; formulation of inhaled therapeutics; research and development of inhaled therapeutics; formulation of pharmaceuticals for oral and intra-oral delivery systems; research and development of pharmaceuticals for oral and intra-oral delivery systems
Case File Event Statements
  • 8/1/2023 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/3/2023 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 7/5/2023 - 2 years ago
    3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 9/14/2023 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/14/2023 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/14/2023 - 2 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/14/2023 - 2 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/14/2023 - 2 years ago
    8 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/14/2023 - 2 years ago
    9 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/14/2023 - 2 years ago
    10 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/14/2023 - a year ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/14/2023 - a year ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/15/2023 - a year ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/23/2024 - a year ago
    16 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 4/23/2024 - a year ago
    15 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 4/23/2024 - a year ago
    14 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 11/6/2024 - 11 months ago
    17 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/14/2024 - 11 months ago
    19 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/14/2024 - 11 months ago
    21 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/14/2024 - 11 months ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/14/2024 - 11 months ago
    18 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/14/2024 - 11 months ago
    20 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/4/2024 - 10 months ago
    23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/10/2024 - 10 months ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/10/2024 - 10 months ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/4/2025 - 8 months ago
    26 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/25/2025 - 2 months ago
    28 - SOU EXTENSION 1 FILED Type: EXT1
  • 7/25/2025 - 2 months ago
    27 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/25/2025 - 2 months ago
    29 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 7/26/2025 - 2 months ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA